Medipower (Overseas) Public Co. Limited Logo

Medipower (Overseas) Public Co. Limited

MDPR.TA

(0.0)
Stock Price

537,30 ILA

1.97% ROA

6.69% ROE

8.55x PER

Market Cap.

69.416.142,64 ILA

185.92% DER

0% Yield

21.22% NPM

Medipower (Overseas) Public Co. Limited Stock Analysis

Medipower (Overseas) Public Co. Limited Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Medipower (Overseas) Public Co. Limited Fundamental Stock Analysis
# Analysis Rating
1 ROE

Unidentified ROE

2 ROA

Unidentified ROA

3 PBV

Unidentified ROA

4 DER

Unidentified DER

5 Revenue Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

6 Net Profit Growth

Throughout the last five years, this company's net profit has remained unchanged, indicating a lack of growth and making it a less favorable investment option.

7 Assets Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

8 Graham Number

Unidentified Graham Number

9 Dividend Growth

The company's dividend growth has remained unchanged for three years, signaling a lack of positive momentum and making it a less favorable investment choice.

10 Dividend

The company has not distributed any dividends in the past three years, which may raise concerns for investors looking for regular income from their investments.

11 Buffet Intrinsic Value

The company's stock shows signs of being overvalued (0) according to Warren Buffett's formula, indicating a potential downside as its market price exceeds its estimated intrinsic value.

Medipower (Overseas) Public Co. Limited Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Medipower (Overseas) Public Co. Limited Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Medipower (Overseas) Public Co. Limited Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Medipower (Overseas) Public Co. Limited Revenue
Year Revenue Growth
2012 45.203.905
2013 14.316.000 -215.76%
2014 13.885.000 -3.1%
2015 12.024.000 -15.48%
2016 11.851.000 -1.46%
2017 15.315.000 22.62%
2018 19.392.000 21.02%
2019 19.114.000 -1.45%
2020 23.975.000 20.28%
2021 30.802.000 22.16%
2022 37.542.000 17.95%
2023 38.621.000 2.79%
2024 38.408.000 -0.55%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Medipower (Overseas) Public Co. Limited Research and Development Expenses
Year Research and Development Expenses Growth
2012 0
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Medipower (Overseas) Public Co. Limited General and Administrative Expenses
Year General and Administrative Expenses Growth
2012 9.487.331
2013 2.323.000 -308.41%
2014 2.005.000 -15.86%
2015 1.706.000 -17.53%
2016 1.672.000 -2.03%
2017 1.739.000 3.85%
2018 1.626.000 -6.95%
2019 1.461.000 -11.29%
2020 1.660.000 11.99%
2021 2.120.000 21.7%
2022 2.572.000 17.57%
2023 2.588.000 0.62%
2024 2.636.000 1.82%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Medipower (Overseas) Public Co. Limited EBITDA
Year EBITDA Growth
2012 918.489
2013 -2.594.000 135.41%
2014 -7.344.000 64.68%
2015 -4.421.000 -66.12%
2016 -2.249.000 -96.58%
2017 -3.617.000 37.82%
2018 -6.575.000 44.99%
2019 -5.983.000 -9.89%
2020 -10.819.000 44.7%
2021 -5.851.000 -84.91%
2022 -19.308.000 69.7%
2023 -13.502.000 -43%
2024 -9.288.000 -45.37%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Medipower (Overseas) Public Co. Limited Gross Profit
Year Gross Profit Growth
2012 45.203.905
2013 14.316.000 -215.76%
2014 13.885.000 -3.1%
2015 12.024.000 -15.48%
2016 11.851.000 -1.46%
2017 15.315.000 22.62%
2018 19.392.000 21.02%
2019 19.114.000 -1.45%
2020 23.975.000 20.28%
2021 30.802.000 22.16%
2022 37.542.000 17.95%
2023 38.621.000 2.79%
2024 38.408.000 -0.55%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Medipower (Overseas) Public Co. Limited Net Profit
Year Net Profit Growth
2012 11.264.572
2013 6.103.000 -84.57%
2014 -862.000 808%
2015 -1.140.000 24.39%
2016 1.974.000 157.75%
2017 4.539.000 56.51%
2018 4.584.000 0.98%
2019 4.127.000 -11.07%
2020 2.531.000 -63.06%
2021 9.189.000 72.46%
2022 1.345.000 -583.2%
2023 8.004.000 83.2%
2024 9.920.000 19.31%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Medipower (Overseas) Public Co. Limited Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2012 1
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Medipower (Overseas) Public Co. Limited Free Cashflow
Year Free Cashflow Growth
2012 -1.978.861
2013 1.193.000 265.87%
2014 1.366.000 12.66%
2015 608.000 -124.67%
2016 3.627.000 83.24%
2017 4.176.999 13.17%
2018 5.423.000 22.98%
2019 7.107.000 23.69%
2020 8.450.000 15.89%
2021 9.502.000 11.07%
2022 12.844.000 26.02%
2023 12.000.000 -7.03%
2024 4.435.000 -170.57%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Medipower (Overseas) Public Co. Limited Operating Cashflow
Year Operating Cashflow Growth
2012 -1.963.926
2013 1.195.000 264.35%
2014 1.368.000 12.65%
2015 611.000 -123.9%
2016 3.627.000 83.15%
2017 4.176.999 13.17%
2018 5.423.000 22.98%
2019 7.107.000 23.69%
2020 8.450.000 15.89%
2021 9.502.000 11.07%
2022 12.928.000 26.5%
2023 12.000.000 -7.73%
2024 4.435.000 -170.57%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Medipower (Overseas) Public Co. Limited Capital Expenditure
Year Capital Expenditure Growth
2012 14.935
2013 2.000 -646.7%
2014 2.000 0%
2015 3.000 33.33%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 84.000 100%
2023 0 0%
2024 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Medipower (Overseas) Public Co. Limited Equity
Year Equity Growth
2012 125.736.080
2013 37.916.999 -231.61%
2014 36.969.999 -2.56%
2015 34.838.000 -6.12%
2016 52.259.000 33.34%
2017 74.573.000 29.92%
2018 75.399.000 1.1%
2019 78.173.000 3.55%
2020 80.926.000 3.4%
2021 111.223.000 27.24%
2022 132.204.000 15.87%
2023 141.360.999 6.48%
2024 143.981.000 1.82%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Medipower (Overseas) Public Co. Limited Assets
Year Assets Growth
2012 508.175.238
2013 130.475.000 -289.48%
2014 124.349.000 -4.93%
2015 99.173.000 -25.39%
2016 146.413.000 32.26%
2017 198.338.000 26.18%
2018 192.237.000 -3.17%
2019 218.591.000 12.06%
2020 265.253.000 17.59%
2021 403.018.000 34.18%
2022 420.697.000 4.2%
2023 416.570.000 -0.99%
2024 417.189.000 0.15%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Medipower (Overseas) Public Co. Limited Liabilities
Year Liabilities Growth
2012 382.439.157
2013 92.558.000 -313.19%
2014 87.379.000 -5.93%
2015 64.334.999 -35.82%
2016 94.154.000 31.67%
2017 123.765.000 23.93%
2018 116.838.000 -5.93%
2019 140.418.000 16.79%
2020 184.327.000 23.82%
2021 291.795.000 36.83%
2022 288.493.000 -1.14%
2023 275.209.000 -4.83%
2024 234.462.000 -17.38%

Medipower (Overseas) Public Co. Limited Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0.75
Net Income per Share
0.16
Price to Earning Ratio
8.55x
Price To Sales Ratio
1.79x
POCF Ratio
5.15
PFCF Ratio
5.09
Price to Book Ratio
0.56
EV to Sales
7.69
EV Over EBITDA
-23.15
EV to Operating CashFlow
21.84
EV to FreeCashFlow
21.84
Earnings Yield
0.12
FreeCashFlow Yield
0.2
Market Cap
0,07 Bil.
Enterprise Value
0,30 Bil.
Graham Number
2.95
Graham NetNet
-4.42

Income Statement Metrics

Net Income per Share
0.16
Income Quality
1.66
ROE
0.07
Return On Assets
0.02
Return On Capital Employed
0.06
Net Income per EBT
0.76
EBT Per Ebit
0.46
Ebit per Revenue
0.61
Effective Tax Rate
0.22

Margins

Sales, General, & Administrative to Revenue
0.07
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
1
Operating Profit Margin
0.61
Pretax Profit Margin
0.28
Net Profit Margin
0.21

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
0.26
Free CashFlow per Share
0.26
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
0.05
Return on Tangible Assets
0.02
Days Sales Outstanding
0
Days Payables Outstanding
0
Days of Inventory on Hand
0
Receivables Turnover
0
Payables Turnover
0
Inventory Turnover
0
Capex per Share
0

Balance Sheet

Cash per Share
0,12
Book Value per Share
3,54
Tangible Book Value per Share
3.54
Shareholders Equity per Share
2.44
Interest Debt per Share
4.54
Debt to Equity
1.86
Debt to Assets
0.56
Net Debt to EBITDA
-17.75
Current Ratio
0
Tangible Asset Value
0,18 Bil.
Net Current Asset Value
-0,23 Bil.
Invested Capital
390072000
Working Capital
0,01 Bil.
Intangibles to Total Assets
0
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
0
Debt to Market Cap
3.38

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Medipower (Overseas) Public Co. Limited Dividends
Year Dividends Growth
2019 50

Medipower (Overseas) Public Co. Limited Profile

About Medipower (Overseas) Public Co. Limited

Medipower (Overseas) Public Co. Limited operates as a commercial real estate company in the United States, Canada, and Bulgaria. It owns and manages retail properties and residential developments, as well as shopping centers. Medipower (Overseas) Public Co. Limited was incorporated in 2001 and is based in Nicosia, Cyprus.

CEO
Mr. Ron Yoseff Stern
Employee
0
Address
1 C. Skokou
Nicosia, 1061

Medipower (Overseas) Public Co. Limited Executives & BODs

Medipower (Overseas) Public Co. Limited Executives & BODs
# Name Age
1 Mr. Shay Yehuda
Accountant
70
2 Mr. Ron Yoseff Stern
Chief Executive Officer
70
3 Ms. Hila Erez Cohen
Chief Financial Officer
70

Medipower (Overseas) Public Co. Limited Competitors

A. Libental Holdings Ltd Logo
A. Libental Holdings Ltd

LBTL.TA

(1.5)
Shemen Industries Ltd Logo
Shemen Industries Ltd

SMNIN.TA

(1.8)
Ravad Ltd Logo
Ravad Ltd

RAVD.TA

(0.0)